Refractory ANCA-associated vasculitis

Rheumatology key messagesEarly induction of remission at presentation and during subsequent flare is paramount to minimise damage accrual.Cardiac involvement is associated with poor outcomes and aggressive treatment is necessary.Combination of cyclophosphamide and rituximab may be needed in certain patients to bring the disease under control. Plasma exchange and/or IVIG may be added as adjunctive therapies.
Source: Rheumatology - Category: Rheumatology Source Type: research